Datavault AI Inc. (NASDAQ: DVLT), a leader in AI-powered data experience, valuation, and monetization, today announced an exclusive licensing agreement with Wellgistics Health Inc. (NASDAQ: WGRX) for the integration of Datavault’s proprietary blockchain-enabled smart-contract patent portfolio. The strategic deal positions Wellgistics to emerge as a Web 3.0 health-information transfer leader across the $634 billion U.S. prescription drug market .
Datavault AI (NASDAQ: DVLT) exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) for integration into the PharmacyChain(TM) and EinsteinRx(TM) platforms, enabling Web 3.0 smart contract functions across a network of more than 6,500 pharmacies and supporting Wellgistics’ plan to streamline prescription tracking, reduce PBM-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution through data automation and AI integration.
Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution expected in January 2026
TAMPA, FL / ACCESS Newswire / November 20, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the individual patient fulfillment of prescription drug through pharmacies ‘From Manufacturer To Patient', today reported financial results for the period ended September 30, 2025 on Form 10-Q on November 19, 2025[1] and provided a business update from the CEO.
TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030
Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturers
KareRx to add plug & play telemedicine pharmacy-support vertical and key manufacturer relationships to Wellgistics' offeringTelemedicine remote dispensing market expected...
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation, and monetization, has entered a SaaS agreement with Wellgistics Health Inc. (NASDAQ: WGRX) to co-develop PharmacyChain(TM), a blockchain-enabled smart contract system designed to optimize prescription distribution from manufacturers to patients. The collaboration leverages Datavault AI’s patented Information Data Exchange(R) platform to create secure, token-driven data transfers that enhance transparency and efficiency in pharmaceutical logistics. CEO Nathaniel Bradley said the partnership will build digital twins of logistics, delivery systems, and patients, supporting personalized health recommendations and new revenue streams in the $639 billion prescription drug market.
Tampa, Florida and Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2025) - Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics"), a leader in next-generation pharmaceutical...
New York, NY – October 24, 2025 – Wellgistics Health, Inc. (NASDAQ: WGRX), a prominent pharmaceutical wholesaler and distributor, experienced an extraordinary surge in its stock price today, rocketing by an astounding 168.16%. This dramatic market reaction follows the company's groundbreaking announcement of its intent to integrate blockchain-enabled smart contracts into
